Close Menu
Home » Interpace Diagnostics Shows Pancreatic Cyst Test Improves Patient Management

Interpace Diagnostics Shows Pancreatic Cyst Test Improves Patient Management

Feb 03, 2016
|
Madeleine Johnson
Premium

NEW YORK (GenomeWeb) – Molecular diagnostics developer Interpace Diagnostics has announced the publication of a multicenter study demonstrating that its PancraGen molecular test for pancreatic cysts improved outcomes for patients and helped doctors monitor patients with benign disease.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

You may already have institutional access!

Check if I qualify.

Already a GenomeWeb or 360Dx Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

Walking Around

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

For Better Identification

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

There, In the Water

The New York Times reports on how environmental DNA sampling could monitor endangered species.

Cell Studies Look at Endometrial Cancer 'Omics, Antibiotic Discovery Deep Learning, Lymphoma

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.

Mar
18
Featured Webinar

Comparison of Genome-Wide versus Targeted cfDNA Testing for First-Line Prenatal Screening: Real-World Data

Sponsored by
Roche

This webinar will discuss data from a recent real-world comparison study evaluating performance of two cell-free DNA methodologies as first-line prenatal screens.

Mar
31
Featured Webinar

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsored by
Isoplexis

This webinar will discuss the application of single-cell proteomics and immune-imaging in adoptive cell therapy (ACT) for cancer.

What's Popular?

In PCR

  1. BioMérieux Reports 11 Percent Revenue Growth in Q4

  2. Co-Diagnostics SARS-CoV-2 Assay Garners CE Mark

  3. Q&A: Hong Kong University's Leo Poon Discusses Diagnostics for SARS-CoV-2

    Premium

  4. New T2 Biosystems CEO Plans to Shrink Costs, Sharpen Sales Strategy

    Premium

  5. Co-Diagnostics Announces $4.2M Direct Offering

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.